report by BlackRock
Results for ""
Investing Ideas
Factors, Sectors, Countries: Opportunities in Emerging Markets
This piece is approved to use with clients.
As we entered 2022, many emerging markets were already hurting. Let's take a deeper dive into how we're looking at emerging markets in light of higher commodity prices, rising rates, and the war in Ukraine.
Market Outlooks
Before and After: How Ukraine Changed Our Outlook
This piece is approved to use with clients.
Just when we thought the world economy was regaining its footing, a military conflict in Europe has led us to reconsider our outlook for growth and inflation.
Market Outlooks
Tectonic Shifts in the Investing Landscape
This piece is approved to use with clients.
Much like the heat from radioactive processes inside the Earth causes tectonic plates to move—sometimes in one direction and sometimes in another—the dynamic shifting of corporate winners and losers remains a constant.
Market Outlooks
10 Reasons We Still Like Industrials
This piece is approved to use with clients.
As the Ukraine conflict continues and COVID ramps up in parts of the world, it seems like all eyes are focused on supply-chain dynamics and labor shortages, which could, in theory, bode poorly for industrials—but a recent research trip abroad only solidified our view that these stocks are well positioned for growth (and deserve their overweight in our broader global equity portfolios). Here are 10 observations about industrials.
Market Outlooks
AAM Viewpoints: A dive into 2020 Fixed Income Markets & what they tell us for 2021
This piece is approved to use with clients.
The unfolding of diverse and largely unseen set of events in 2020 make it difficult to select only a few that we feel represent the tenor of the fixed income markets and the broad economy within this commentary. Clearly, the migration back into risk assets beginning in Q2 (the 2nd quarter) continued through Q4 2020 buttressed by what we think can be four primary causes:
Market Outlooks
AAM Viewpoints: Let’s party like it’s 1999!
This piece is approved to use with clients.
As the calendar changed from 2020 to 2021, I can’t help but find an environment that is truly surreal. We have a raging global pandemic on our hands that is getting markedly worse on a day-by-day basis, we have vaccines that are sitting in warehouses being administered at one-tenth the rate that is necessary to accomplish the task at hand and we have millions without a job with difficult prospects of getting one in the near future.
Market Outlooks
AAM Viewpoints: Equity market side effects of the covid-19 vaccine
This piece is approved to use with clients.
The 337 days spanning the World Health Organization’s announcement of COVID-19 to the FDA approval of the first vaccine the world witnessed many social, economic, and scientific events few thought possible.
Market Outlooks
AAM Viewpoints: Light at the end of the tunnel
This piece is approved to use with clients.
The year 2020 and the start of 2021 will be burned into the collective consciousness for quite some time for a myriad of reasons and given this we probably shouldn’t rehash every headline here. However, from an investment standpoint we can summarize 2020 very simply as: